KD2-305 phase II/III study
Latest Information Update: 17 Dec 2021
At a glance
- Drugs Factor VII-KM Biologics (Primary)
- Indications Haemophilia A; Haemophilia B
- Focus Adverse reactions; Therapeutic Use
- Sponsors KM Biologics
- 17 Dec 2021 New trial record